www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Companies

Bayer making deep inroads across China

By Zhang Zhao (China Daily) Updated: 2015-05-06 09:13

Bayer making deep inroads across China

Alok Kanti, managing director of Bayer HealthCare China, holds a scroll reading "innovation" in Chinese to illustrate the company's focus at a recent press conference. [Photo/China Daily]

Bayer HealthCare reaffirmed its leading position in China's healthcare industry with sales of some 1.66 billion euros ($1.85 billion) in the country last year, a 14 percent growth from 2013.

At a recent press conference in Beijing, the company said its pharmaceuticals business grew at an annual rate of 15 percent in China, with a 26 percent spike in its consumer care business and 11 percent growth in its animal healthcare division.

"Our success in China is based on our company's innovation capabilities and patient-focused treatment options," said Alok Kanti, managing director of Bayer HealthCare China.

Based on a forecast by IMS Health, an agency that provides global information on the health industry, the pharmaceutical market in China will grow 9.3 percent from 2014 to 2019, compared to 6.1 percent globally over the same period.

"This is largely because of the size of China's market and its number of patients," Kanti said.

"As people age and as the economy becomes industrialized, disease profiles change," he said. "Despite existing technologies, there is a higher amount of unmet needs."

He pointed to hypertension as one example. One-third of Chinese adults suffer from the disease but only 34 percent of those patients receive treatment, a far cry from the United States, where 77 percent of hypertensive patents get treatment.

The second driver in the nation's overall growth is the central government's recognition of the importance of healthcare, which has led to "significant and rapid investment", said Kanti, who added that the Chinese government is focusing on medical infrastructure in rural areas and tackling diseases that can have a major impact on a small population, such as hemophilia.

Kanti said Bayer is looking at global diseases "where there is no cure today or five years ago" by making major investments in research and development to find cures.

Bayer offers a wide range of medicines, from anti-infectives and cancer-treatment drugs to women's health products.

Last year, it strengthened its consumer care business by acquiring the over-the-counter drug business of US pharmaceutical company Merck & Co Inc and Chinese firm Dihon Pharmaceutical Group, which produces herbal medicines.

The acquisitions made Bayer HealthCare not only the second largest producer of OTC products around the world, but a leading OTC player in China.

Acquiring Dihon "allows us an entry point into the very important area of traditional Chinese medicine", Kanti said, and access to smaller Chinese cities through Dihon's sales networks.

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 老司机午夜性生免费福利 | 国产日韩欧美 | 黄色网址亚洲 | 国产成人91精品 | 国产精品成人免费视频不卡 | 毛片在线免费视频 | 日本三级香港三级乳网址 | hdxxx色视频 hd欧美xxx欧美极品hd | heyzo国产亚洲高清 | 欧美一级视频在线 | 国内精品不卡一区二区三区 | 欧美一级毛片在线播放 | 日韩一区二区三区四区不卡 | 青青青青爽视频在线播放 | 成人影院欧美大片免费看 | 亚洲加勒比在线 | 欧美一级毛片图 | 玖玖玖视频在线观看视频6 玖玖影院在线观看 | 三级中文字幕永久在线视频 | 成人毛片免费观看视频 | 国产片在线天堂av | 99r8这是只有精品视频9 | 国产精品资源 | 国产毛片精品 | 欧美一级片毛片 | 男女免费视频网站 | 日本不卡一二三区 | 欧美在线看欧美高清视频免费 | 国产成人3p视频免费观看 | 欧美大尺码毛片 | 欧美午夜毛片a级在线 | 亚洲精品欧美精品国产精品 | 久久精品视频一区二区三区 | 国产老头与老太hd | 日本理论片免费高清影视在线观看 | 久久小视频 | 99久久这里只精品国产免费 | www.久草视频| 天干天干天啪啪夜爽爽色 | 国产成人mv在线观看入口视频 | 亚洲成人福利网站 |